Stereotactic body radiation therapy (SBRT) for lung cancer increases one's risk of non-cancer death
A type of radiotherapy called stereotactic body radiation therapy (SBRT) can put patients with early stage non-small cell lung cancer (NSCLC) at an increased risk of death from causes other than cancer, according to a new study.










